In FXS, the methylation of the FM together with the neighbouring CpG island of the FMR1 promoter triggers the silencing of the FMR1 gene, leading to the absence or a drastic reduction of FMRP during development [25]. The gene discussed is FMR1; the disease is fragile X syndrome.